
Count data and recurrent events in clinical trials, such as the number of
lesions in magnetic resonance imaging in multiple sclerosis, the number of
relapses in multiple sclerosis, the number of hospitalizations in heart
failure, and the number of exacerbations in asthma or in chronic obstructive
pulmonary disease (COPD) are often modeled by negative binomial distributions.
In this manuscript we study planning and analyzing clinical trials with group
sequential designs for negative binomial outcomes. We propose a group
sequential testing procedure for negative binomial outcomes based on Wald
statistics using maximum likelihood estimators. The asymptotic distribution of
the proposed group sequential tests statistics are derived. The finite sample
size properties of the proposed group sequential test for negative binomial
outcomes and the methods for planning the respective clinical trials are
assessed in a simulation study. The simulation scenarios are motivated by
clinical trials in chronic heart failure and relapsing multiple sclerosis,
which cover a wide range of practically relevant settings. Our research assures
that the asymptotic normal theory of group sequential designs can be applied to
negative binomial outcomes when the hypotheses are tested using Wald statistics
and maximum likelihood estimators. We also propose two methods, one based on
Student's tdistribution and one based on resampling, to improve type I error
rate control in small samples. The statistical methods studied in this
manuscript are implemented in the R package \textit{gscounts}, which is
available for download on the Comprehensive R Archive Network (CRAN).

In confirmatory clinical trials with small sample sizes, hypothesis tests
based on asymptotic distributions are often not valid and exact nonparametric
procedures are applied instead. However, the latter are based on discrete test
statistics and can become very conservative, even more so, if adjustments for
multiple testing as the Bonferroni correction are applied. We propose improved
exact multiple testing procedures for the setting where two parallel groups are
compared in multiple binary endpoints. Based on the joint conditional
distribution of test statistics of Fisher's exact tests, optimal rejection
regions for intersection hypotheses tests are constructed. To efficiently
search the large space of possible rejection regions, we propose an
optimization algorithm based on constrained optimization and integer linear
programming. Depending on the optimization objective, the optimal test yields
maximal power under a specific alternative, maximal exhaustion of the nominal
type I error rate, or the largest possible rejection region controlling the
type I error rate. Applying the closed testing principle, we construct
optimized multiple testing procedures with strong familywise error rate
control. Furthermore, we propose a greedy algorithm for nearly optimal tests,
which is computationally more efficient. We numerically compare the
unconditional power of the optimized procedure with alternative approaches and
illustrate the optimal tests with a clinical trial example in a rare disease.

We describe a general framework for weighted parametric multiple test
procedures based on the closure principle. We utilize general weighting
strategies that can reflect complex study objectives and include many
procedures in the literature as special cases. The proposed weighted parametric
tests bridge the gap between rejection rules using either adjusted significance
levels or adjusted $p$values. This connection is possible by allowing
intersection hypotheses to be tested at level smaller than $\alpha$, which may
be needed for certain study considerations. For such cases we introduce a
subclass of exact $\alpha$level parametric tests which satisfy the consonance
property. When only subsets of test statistics are correlated, a new procedure
is proposed to fully utilize the parametric assumptions within each subset. We
illustrate the proposed weighted parametric tests using a clinical trial
example.

Statistical methodology for the design and analysis of clinical Phase II dose
response studies, with related software implementation, are well developed for
the case of a normally distributed, homoscedastic response considered for a
single timepoint in parallel group study designs. In practice, however, binary,
count, or timetoevent endpoints are often used, typically measured repeatedly
over time and sometimes in more complex settings like crossover study designs.
In this paper we develop an overarching methodology to perform efficient
multiple comparisons and modeling for dose finding, under uncertainty about the
doseresponse shape, using general parametric models. The framework described
here is quite general and covers dose finding using generalized nonlinear
models, linear and nonlinear mixed effects models, Cox proportional hazards
(PH) models, etc. In addition to the core framework, we also develop a general
purpose methodology to fit dose response data in a computationally and
statistically efficient way. Several examples, using a variety of different
statistical models, illustrate the breadth of applicability of the results. For
the analyses we developed the R addon package DoseFinding, which provides a
convenient interface to the general approach adopted here.

This note investigates a number of scenarios in which unadjusted testing
following a blinded sample size reestimation leads to type I error violations.
For superiority testing, this occurs in certain smallsample borderline cases.
We discuss a number of alternative approaches that keep the type I error rate.
The paper also gives a reason why the type I error inflation in the superiority
context might have been missed in previous publications and investigates why it
is more marked in case of noninferiority testing.

Highdimensional tests are applied to find relevant sets of variables and
relevant models. If variables are selected by analyzing the sums of products
matrices and a corresponding meanvalue test is performed, there is the danger
that the nominal error of first kind is exceeded. In the paper, wellknown
multivariate tests receive a new mathematical interpretation such that the
error of first kind of the combined testing and selecting procedure can more
easily be kept. The null hypotheses on mean values are replaced by hypotheses
on distributional sphericity of the individual score responses. Thus, model
choice is possible without too strong restrictions. The method is presented for
all linear multivariate designs. It is illustrated by an example from
bioinformatics: The selection of gene sets for the comparison of groups of
patients suffering from Bcell lymphomas.